Evidence map›Paper›PMID 27443614›Full record

ArticleThe Journal of infectious diseases2016

Dynamics of Dengue Virus (DENV)-Specific B Cells in the Response to DENV Serotype 1 Infections, Using Flow Cytometry With Labeled Virions.

Marcia Woda, Heather Friberg, Jeffrey R Currier, Anon Srikiatkhachorn, Louis R Macareo, Sharone Green, Richard G Jarman, Alan L Rothman, Anuja Mathew

Abstract readEvaluation Study
In one paragraph

Article in The Journal of infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marcia WodaDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester Institute for Immunology and Informatics, University of Rhode Island, Providence.
Heather FribergWalter Reed Army Institute of Research, Silver Spring, Maryland.
Jeffrey R CurrierWalter Reed Army Institute of Research, Silver Spring, Maryland.
Anon SrikiatkhachornDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Louis R MacareoDepartment of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Sharone GreenDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester.
Richard G JarmanWalter Reed Army Institute of Research, Silver Spring, Maryland.
Alan L RothmanInstitute for Immunology and Informatics, University of Rhode Island, Providence.
Anuja MathewDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester Institute for Immunology and Informatics, University of Rhode Island, Providence.

Funding

VIRAL DETERMINANTS OF SEVERE DENGUE DISEASEP01AI034533 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ROTHMAN, ALAN L · 1994 to 2022
$42.0M
Technologies for Human Cellular ImmunologyU19AI057319 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ROTHMAN, ALAN L · 2003 to 2013
$34.4M
NK cell regulation of immune responses to dengueR21AI113479 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MATHEW, ANUJA · 2015 to 2016
$425k
NIAID NIH HHS P01 AI034533NIAID NIH HHS R21 AI113479NIAID NIH HHS U19 AI057319
6 · The paper itself

Abstract

backgroundThe development of reagents to identify and characterize antigen-specific B cells has been challenging.

methodsWe recently developed Alexa Fluor-labeled dengue viruses (AF DENVs) to characterize antigen-specific B cells in the peripheral blood of DENV-immune individuals.

resultsIn this study, we used AF DENV serotype 1 (AF DENV-1) together with AF DENV-2 on peripheral blood mononuclear cells (PBMCs) from children in Thailand with acute primary or secondary DENV-1 infections to analyze the phenotypes of antigen-specific B cells that reflected their exposure or clinical diagnosis. DENV serotype-specific and cross-reactive B cells were identified in PBMCs from all subjects. Frequencies of AF DENV(+) class-switched memory B cells (IgD(-)CD27(+) CD19(+) cells) reached up to 8% during acute infection and early convalescence. AF DENV-labeled B cells expressed high levels of CD27 and CD38 during acute infection, characteristic of plasmablasts, and transitioned into memory B cells (CD38(-)CD27(+)) at the early convalescent time point. There was higher activation of memory B cells early during acute secondary infection, suggesting reactivation from a previous DENV infection.

conclusionsAF DENVs reveal changes in the phenotype of DENV serotype-specific and cross-reactive B cells during and after natural DENV infection and could be useful in analysis of the response to DENV vaccination.

Indexed as

SerogroupAdolescentB-LymphocytesChildChild, PreschoolDengueDengue VirusFemaleFlow CytometryHumansImmunoassayInfantMaleStaining and LabelingThailandVirionAlexa FluorantigenB cellDengueflow cytometry

Identifiers

PMID27443614
PMCPMC5021233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.